1. 61OOUTCOME OF SURGICAL SALVAGE FOR LOCAL FAILURES FOLLOWING STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR). (16th March 2015) Authors: Verstegen, N.E.; Lagerwaard, F.J.; Paul, M.A.; Smit, E.F.; Versteegh, M.I.M.; Joosten, J.J.A.; Slotman, B.J.; Senan, S. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 1 Page Start: i18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 98O_PRTARGETED THERAPY FOR BRAF-MUTANT LUNG CANCER: RESULTS FROM THE EUROPEAN EURAF COHORT STUDY. (17th April 2015) Authors: Gautschi, O.; Bluthgen, M.V.; Smit, E.F.; Wolf, J.; Früh, M.; Peters, S.; Schuler, M.; Zalcman, G.; Milia, J.; Mazieres, J. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 1 Page Start: i61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. (December 2019) Authors: Thunnissen, E.; Lissenberg-Witte, B.I.; van den Heuvel, M.M.; Monkhorst, K.; Skov, B.G.; Sørensen, J.B.; Mellemgaard, A.; Dingemans, A.M.C.; Speel, E.J.M.; de Langen, A.J.; Hashemi, S.M.S.; Bahce, I.; van der Drift, M.A.; Looijen-Salamon, M.G.; Gosney, J.; Postmus, P.E.; Samii, S.M.S.; Duplaquet,... Journal: Lung cancer Issue: Volume 138(2019) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Costs of non-small cell lung cancer in the Netherlands. (January 2016) Authors: van der Linden, N.; Bongers, M.L.; Coupé, V.M.H.; Smit, E.F.; Groen, H.J.M.; Welling, A.; Schramel, F.M.N.H.; Uyl-de Groot, C.A. Journal: Lung cancer Issue: Volume 91(2016) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Costs of non-small cell lung cancer in the Netherlands. (January 2016) Authors: van der Linden, N.; Bongers, M.L.; Coupé, V.M.H.; Smit, E.F.; Groen, H.J.M.; Welling, A.; Schramel, F.M.N.H.; Uyl-de Groot, C.A. Journal: Lung cancer Issue: Volume 91(2016) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile. (December 2019) Authors: Hermans, B.C.M.; Derks, J.L.; Thunnissen, E.; van Suylen, R.J.; den Bakker, M.A.; Groen, H.J.M.; Smit, E.F.; Damhuis, R.A.; van den Broek, E.C.; Ruland, A.; Speel, E.J.M.; Dingemans, A.M.C. Journal: Lung cancer Issue: Volume 138(2019) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments. (September 2022) Authors: Castenmiller, S.M.; de Groot, R.; Guislain, A.; Monkhorst, K.; Hartemink, K.J.; Veenhof, A.A.F.A.; Smit, E.F.; Haanen, J.B.A.G.; Wolkers, M.C. Journal: Immuno-oncology technology Issue: Volume 15(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry. (February 2020) Authors: Smit, H.J.M.; Aerts, J.; van den Heuvel, M.; Hiltermann, T.J.N.; Bahce, I.; Smit, E.F.; Dingemans, A-M.C.; Hendriks, L.E.; Stigt, J.A.; Schramel, F.M.N.H.; van Tinteren, H.; Groen, H.J.M. Journal: Lung cancer Issue: Volume 140(2020) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study. (March 2020) Authors: Witlox, W.J.A.; Ramaekers, B.L.T.; Joore, M.A.; Dingemans, A.-M.C.; Praag, J.; Belderbos, J.; Tissing-Tan, C.; Herder, G.; Haitjema, T.; Ubbels, J.F.; Lagerwaard, J.; El Sharouni, S.Y.; Stigt, J.A.; Smit, E.F.; van Tinteren, H.; van der Noort, V.; Groen, H.J.M.; De Ruysscher, D.K.M. Journal: Radiotherapy and oncology Issue: Volume 144(2020) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation. (December 2022) Authors: Jänne, P.A.; Smit, E.F.; de Marinis, F.; Laskin, J.; Gomez, M. Domine; Gadgeel, S.; Garassino, M.C.; Lu, S.; Spira, A.S.; Kang, V.; Roshan, S.; Yan, X.; Felip, E. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗